Navigation Links
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays
Date:5/18/2009

seases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

***

This press release contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's performance, including future performance, products or other events or developments that BD expects to occur or anticipates occurring in the future. All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Factors that could cause actual results to vary materially from any forward-looking statement include, but are not limited to: competitive factors; pricing and market share pressures; difficulties inherent in product development and delays in product introductions; changes in regional, national or foreign economic conditions; increases in energy costs and their effect on, among other things, the cost of producing BD's products; fluctuations in costs and availability of raw materials and in BD's ability to maintain favorable supplier arrangements and relationships; changes in healthcare or other governmental regulation; as well as other factors discussed in this press release and in BD's filings with the Securities and Exchange Commission. We do not intend to update any forward-looking statements to reflect events or cir
'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Abbott Announces EuroPCR 2009 Activities
2. COPD Foundation announces launch of Lung Health Check on WebMD
3. Haiti Hosts Opening Ceremony of the 2009 International AIDS Candlelight Memorial: Worldwide Events Commence With the Announcement of a National HIV Testing Campaign in Haiti
4. AMDL, Inc. Announces First Quarter 2009 Financial Results
5. LifeCare Holdings, Inc. Announces First Quarter Results
6. XTENT, Inc. Announces Approval of Plan of Liquidation and Dissolution by Board of Directors and Filing of Proxy Materials With the SEC
7. Thoratec Announces Appointment of Paul LaViolette to Board of Directors
8. HealthWarehouse.com, Inc. Announces Completion of Business Combination With Clacendix, Inc.
9. BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting
10. Smith & Nephew Orthopaedics Announces First Contribution to OREF Grants Fund
11. Cigna Medical Group Announces Grand Opening of CareToday Clinic in Anthem, Ariz.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 University of ... officially opened the doors of its state-of-the-art, $151 million ... the heart of downtown San Francisco's South of Market ... patients a year. Those patients will now be greeted ... iKiosks . , Advanced Kiosks engineering team ...
(Date:7/22/2014)... of the deadly MERS virus were detected in the air ... new study says. The findings show the need for ... can be transmitted through the air, the researchers said. ... camel barn owned by a 43-year-old male MERS patient who ... man later died. One of the camels in the barn ...
(Date:7/22/2014)... stimulation treatments, like electroconvulsive therapy (ECT) and transcranial ... treatment of depression. Like antidepressant medications, however, they ... patient may receive several weeks of regular ECT ... Thus, there is an impetus to develop antidepressant ... field magnetic stimulation (LFMS) is one such potential ...
(Date:7/22/2014)... The “Human Insulin Market by Product Type ... Human Insulin (Rapid Acting, Long Acting, Premixed)], by ... - Forecast to 2019” provides a detailed overview ... market trends, and strategies impacting the global human ... of the revenue and share analysis. , Browse ...
(Date:7/22/2014)... 22, 2014 Cloud+MD Office 2.0 ... interoperable suite of medical software and services, designed ... providers, that produces “Actionable Information” to help Independent ... Systems and Billing Services optimize a wide range ... Quality, Greater Efficiency, Noticeable Cost Reductions and Better ...
Breaking Medicine News(10 mins):Health News:iKiosks Are Gateway to Premier Dental Facility 2Health News:iKiosks Are Gateway to Premier Dental Facility 3Health News:MERS Virus Found in Air in Camel Barn 2Health News:Low strength brain stimulation may be effective for depression 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Cloud-MD Software will soon Receive MU2 Certification 2
... ... tissue and muscle pain therapy called the Active Release Technique. Active Release Technique is ... ... downtown NYC office, noted local chiropractor, Dr. Steven Shoshany, has recently expanded his ...
... A team of American psychologists and neuroscientists have found ... Anorexia Nervosa, can be regained. The research, published in ... that through specialist treatment patients with this eating disorder ... Anorexia Nervosa (AN) is a serious psychiatric ...
... ... MBA HealthGroup partner to increase physician adoption of electronic health records statewide , ... (PRWEB) May 26, 2010 ... Vermont, announced today that Vermont Information Technology Leaders, Inc. (VITL), the non-profit ...
... ... of Medical Services That Wastes Over 20 Cents of Every Dollar Spent , ... Lexington, MA (PRWEB) May 26, 2010 -- ... which are pivotal to the national healthcare debate, in the May issue of the ...
... ... DSPanel today announced the availability of their latest ... DSPanel announced the availability of DSPanel Performance Canvas 2.2 with Planning, ... designed to be used as an accompaniment to Sharepoint 2010 and ...
... ... to prescription sunglasses , ... New Jersey (PRWEB) May 26, 2010 -- With summer quickly approaching, GlassesUSA.com getting ... prescription glasses has been selling prescription sunglasses since the store opened. ...
Cached Medicine News:Health News:NYC Chiropractor Expands Practice with Therapy for Muscle and Overuse Injuries 2Health News:Brain volume found to change following weight gain in adults with anorexia 2Health News:MBA HealthGroup Selected as Preferred Partner by VITL 2Health News:HealthMETRICS Partners, Inc. Article in AJMC Outlines Innovative Approach to Combat Rising Healthcare Costs 2Health News:DSPanel's New Mobile Analytics Server for Business Intelligence: Data Analysis, Monitoring and Planning When and Where You Need It 2Health News:DSPanel's New Mobile Analytics Server for Business Intelligence: Data Analysis, Monitoring and Planning When and Where You Need It 3Health News:GlassesUSA.com Launches Section for Prescription Sunglasses 2
(Date:7/22/2014)... July 22, 2014  Halozyme Therapeutics, Inc. (NASDAQ: ... enrollment and dosing of patients in its ongoing Phase ... pancreatic cancer under the revised clinical protocol agreed to ... PEGylated form of Halozyme,s proprietary recombinant human hyaluronidase under ... hyaluronan. "Our diligent effort to rapidly ...
(Date:7/22/2014)... -- ConvaTec, a privately-held medical products and technologies company, today ... chief financial officer of the company, effective July 22, ... president and chief financial officer of Elan Corporation, a ... was part of a senior team that helped build ... to Perrigo, a pharmaceutical manufacturer, in December 2013. ...
(Date:7/22/2014)... , July 22, 2014  UL (Underwriters ... that the U.S. Food and Drug Administration (FDA) ... consensus standards for medical devices incorporating lithium or ... - Standard for Household and Commercial Batteries, and ... Consensus standards are standards recognized ...
Breaking Medicine Technology:Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3ConvaTec Names Nigel Clerkin Chief Financial Officer 2Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices 2
... HARBIN, China , July 7 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, ... and distributor of botanical products,bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced,that, ... on the NYSE Amex,Market under the ticker symbol "CBP". , ... On this occasion, ...
... , SOMERVILLE, N.J. , July 7 ... surgical care, announced today the introduction of ETHICON™ ... designed to achieve adjunctive hemostasis (stoppage of bleeding) ... leakage. The US Food and Drug Administration (FDA) ...
Cached Medicine Technology:Renhuang Begins Trading on NYSE Amex 2Renhuang Begins Trading on NYSE Amex 3Renhuang Begins Trading on NYSE Amex 4Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant 2Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant 3
Take Performance to a Higher Level....
Rapid Exchange Stent Delivery System...
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
... The EVS has an ergonomic ... activated mechanism which requires a ... gently locks onto the target ... the site before, during and ...
Medicine Products: